First-in-human, phase I/IIa clinical study of the peptidase...

Investigational New Drugs 2015 / 12 Vol. 33; Iss. 6

First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies

Berglund, Åke, Ullén, Anders, Lisyanskaya, Alla, Orlov, Sergey, Hagberg, Hans, Tholander, Bengt, Lewensohn, Rolf, Nygren, Peter, Spira, Jack, Harmenberg, Johan, Jerling, Markus, Alvfors, Carina, Ringb
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0299-2
Date:
December, 2015
File:
PDF, 435 KB
english, 2015
Conversion to is in progress
Conversion to is failed